Given the role of protein kinases and phosphatases as master regulators of cell signaling and the involvement of dysregulated or mutated kinases in human tumorigenesis and cancer progression [8,29], these enzymes have been confirmed as valid candidates for the development of new targeted treatments for cancer treatment. The gene discussed is WEE1; the disease is cancer.